AXSM
NASDAQ · Pharmaceuticals
Axsome Therapeutics Inc
$217.38
-2.84 (-1.29%)
Performance
1D
—
1W
—
1M
—
3M
+18.64%
6M
+57.75%
1Y
+101.73%
YTD
+21.65%
Open$220.56
Previous Close$220.22
Day High$223.43
Day Low$216.77
52W High$234.29
52W Low$96.09
Volume—
Avg Volume1.23M
Market Cap11.19B
P/E Ratio—
EPS$-3.69
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$171.07
Above
SMA 200
$131.37
Above
RSI (14)
51.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
-69.6% upside
Current
$217.38
$217.38
Target
$66.03
$66.03
$47.60
$66.03 avg
$88.20
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 660.48M | 1.74B | 1.62B |
| Net Income | -189,480,005 | 523.27M | 458.37M |
| Profit Margin | -28.7% | 30.1% | 28.3% |
| EBITDA | -176,651,085 | 948.73M | 868.54M |
| Free Cash Flow | — | 423.20M | 592.85M |
| Rev Growth | +133.7% | -6.3% | -6.3% |
| Debt/Equity | 3.25 | 0.60 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |